Joana Goncalves
Geen lopende functies
Vermogen: 48 562 $ op 31-03-2024
Profiel
Joana Goncalves worked as the Vice President-Medical Affairs & Neurology at Celgene Corp.
from 2014 to 2018.
Prior to that, she was the VP-Medical Strategy & Scientific Affairs at Leo Pharma, Inc. from 2012 to 2014.
Currently, she is serving as the Chief Medical Officer at CARA Therapeutics, Inc. since 2018.
Dr. Goncalves holds a doctorate degree from the University of Cape Town.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CARA THERAPEUTICS INC
0.10% | 05-04-2024 | 53 365 ( 0.10% ) | 48 562 $ | 31-03-2024 |
Eerdere bekende functies van Joana Goncalves
Bedrijven | Functie | Einde |
---|---|---|
CARA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 16-04-2024 |
CELGENE | Chief Tech/Sci/R&D Officer | 01-10-2018 |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Chief Tech/Sci/R&D Officer | 01-04-2014 |
Opleiding van Joana Goncalves
University of Cape Town | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CARA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |